Insight Molecular Diagnostics Inc. (IMDX) › Total LiabilitiesInsight Molecular Diagnostics Inc. (IMDX) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2015: $2.31M2016: $4.58M2017: $5.81M2018: $6.09M2019: $9.02M2020: $21.94M2021: $94.35M2022: $60.50M2023: $49.30M2024: $47.35M2025: $57.22M$57.22M2015Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$57.22M+20.8%2024$47.35M-3.9%2023$49.30M-18.5%2022$60.50M-35.9%2021$94.35M+330.1%2020$21.94M+143.2%2019$9.02M+48.0%2018$6.09M+4.9%2017$5.81M+26.8%2016$4.58M+98.1%2015$2.31M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share